IP Ownership · Biotechnology
Who owns the patents on mRNA and biotechnology?
mRNA therapeutics, recombinant DNA, monoclonal antibodies, and the platform technologies behind modern vaccines.
Patents indexed
171
Total citations
52,170
Top-3 hold
62% of citations
Assignees ranked
10
Ranked by total forward citations — 10 companies
How to Make Many Copies of a Specific DNA Segment
US 4683202 · 7,558 citations
31%
of citations
Making Hybrid Antibodies from Different Animals
US 4816567 · 8,214 citations
23%
of citations
How Scientists Create Human-Friendly Antibodies for Medicine
US 5585089 · 4,274 citations
8%
of citations
How Doctors Implant a Permanent Stent Using a Balloon
US 4733665 · 2,425 citations
5%
of citations
How to Encapsulate Active Materials in Lipid Bubbles Efficiently
US 4235871 · 1,862 citations
5%
of citations
Boosting Anti-Infective Activity with Muramyldipeptides and Liposomes
US 4522811 · 2,340 citations
4%
of citations
How Two Special Antibodies Find Substances in Body Fluids
US 4376110 · 1,572 citations
3%
of citations
How an Enzyme Helps Find Specific DNA in a Sample
US 5210015 · 1,183 citations
3%
of citations
How to Edit Genes in Human Cells Using an Engineered CRISPR System
US 8697359 · 1,268 citations
2%
of citations
Mice Engineered to Develop Cancer for Research
US 4736866 · 644 citations
1%
of citations
Rankings by total forward citations within PatentBrief's enriched patent corpus for the Biotechnology technology domain. Forward citations are the industry standard proxy for patent influence and commercial importance. Coverage reflects patents currently indexed; the full USPTO corpus is larger.